• IMF: Despite Challenges, Global Economic Growth Expected to Improve

    Head of the International Monetary Fund (IMF) Christine Lagarde stated on Sunday (06/07) that the institution expects improved global economic growth in the second half of 2014 as well as in 2015 supported by the assumption that China, the world’s second-largest economy, will expand between 7.0 and 7.5 percent in 2014, thus not showing a sharp slowdown. Later this month, the IMF will release its new global economic outlook. Lagarde said that forecasts will be slightly different from forecasts made in the April edition.

    Lanjut baca ›

  • Election Indonesia: Last Debate Subianto-Rajasa vs Jokowi-Kalla

    On Saturday 5 July 2014, the fifth presidential debate between the two presidential pairs took place. Candidates Prabowo Subianto (joined by running mate Hatta Rajasa) and Joko “Jokowi” Widodo (joined by running mate Jusuf Kalla) faced off in the last debate. The theme of this debate was 'energy, food security and environment'. Sudharto P. Hadi, Professor of Sociology at the Diponegoro University in Semarang (Central Java) was the moderator. On Wednesday 9 July 2014, the Indonesian people will go to the ballot boxes to elect their next leader.

    Lanjut baca ›

  • Indonesia Investments' Newsletter of 6 July 2014 Released

    On 06 July 2014, Indonesia Investments released the latest edition of its newsletter. This free newsletter, which is sent to our subscribers once per week, contains the most important news stories from Indonesia that have been reported on our website in the last seven days. Most of the topics involve political and economic topics such as the presidential election, a rupiah and stock market update, an analysis of inflation and the trade balance, corruption, poverty, GDP growth, prospects of the copper price, and more.

    Lanjut baca ›

  • Kalbe Farma: a Profile of Indonesia's Largest Pharmaceutical Company

    Indonesia Investments has updated the company profile of PT Kalbe Farma Tbk. Kalbe Farma is the largest listed pharmaceutical company in Indonesia and Southeast Asia (listed on the Indonesia Stock Exchange/IDX). The company’s main business focus rests on four divisions: prescription pharmaceuticals, consumer health products, nutritionals as well as distribution & logistics. Its a leading provider of “comprehensive healthcare solutions”, from pharmaceuticals, nutrition, health foods and beverages to medical devices, including primary healthcare service.

    Lanjut baca ›